Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Fractionation and characterization of the immunosuppressive substance in crude extracellular products released by Streptococcus intermedius.
M P Arala-Chaves, … , C C Patrick, H H Fudenberg
M P Arala-Chaves, … , C C Patrick, H H Fudenberg
Published July 1, 1981
Citation Information: J Clin Invest. 1981;68(1):294-302. https://doi.org/10.1172/JCI110247.
View: Text | PDF
Research Article

Fractionation and characterization of the immunosuppressive substance in crude extracellular products released by Streptococcus intermedius.

  • Text
  • PDF
Abstract

The noncytotoxic immunosuppressive substance detected in crude extracellular products of Streptococcus intermedius (CEP-SI) was fractionated by two steps of preparative isoelectric focusing in sucrose gradients using ampholytes of pH range from 3.5 to 6 and 4 to 5, respectively. The in vitro and in vivo suppressor effects of the most highly purified fraction of CEP-Si, designated fraction 3' (F3'EP-Si), corresponded well with those of the original CEP-Si. F3'EP-Si was sensitive to the effects of alpha, gamma, and delta chymotrypsin, trypsin, and heating. It contained approximately 1% of the total amount of protein found in the original CEP-Si, corresponding to a single band on analytical isoelectric focusing, stainable by Coomassie Blue and of isoelectric point of 4.25. The absorption spectrum of F3'EP-Si had a maximum at 260 nm but its biological activity was resistant to deoxyribonuclease and ribonuclease A and it did not contain material stainable by methylene blue. It was also resistant to neuraminidase and did not contain material stainable by periodic acid schiff. We conclude that the substance responsible for the suppressor activity of CEP-Si is a protein of molecular weight approximately 90,000, which adheres to Sephadex of cellulose acetate and forms complexes with other, nonactive constituents of CEP-Si.

Authors

M P Arala-Chaves, M T Porto, P Arnaud, M J Saraiva, H Geada, C C Patrick, H H Fudenberg

×

Total citations by year

Year: 2011 2008 2006 1993 1992 1991 1988 1987 1986 Total
Citations: 1 1 1 2 2 1 2 1 1 12
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (12)

Title and authors Publication Year
Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis
AH Al-Charrakh, JK Al-Khafaji, RH Al-Rubaye
North American Journal of Medical Sciences 2011
Virulence factors of Anginosus group streptococci
H NAGAMUNE
Nippon Saikingaku Zasshi 2008
The Prokaryotes
M Dworkin, S Falkow, E Rosenberg, KH Schleifer, E Stackebrandt
2006
Peripheral Lymphoid Hyperplasia and Central Lymphoid Depletion in Mice Treated with a Bacterial B-Cell Mitogen (F3'EP-Si/p90)
M Lima, D Portnoi, A Bandeira, MA Chaves
Scandinavian Journal of Immunology 1993
Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host
D Tavares, A Salvador, P Ferreira, M Arala-Chaves
Infection and immunity 1993
Is Prophylactic Immunostimulation of the Host against Pathogenic Microbial Antigens an Adequate Strategy of Immunoprotection?
MP Arala-Chaves
Scandinavian Journal of Immunology 1992
Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius
M Lima, A Bandeira, D Portnoi, A Ribeiro, MA Chaves
Infection and immunity 1992
Stimulation of B and T cells by in vivo high dose immunoglobulin administration in normal mice
A Sundblad, F Huetz, D Portnoï, A Coutinho
Journal of Autoimmunity 1991
Correlation between Specific Immunosuppression and Polyclonal B Cell Activation Induced by a Protein Secreted by Streptococcus mutans
P Ferreira, R Soares, A Ribeiro, M Arala-Chaves
Scandinavian Journal of Immunology 1988
Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen
KL Ruoff
Clinical microbiology reviews 1988
Semi-Purification of an Immunosuppressor Substance Secreted by Streptococcus mutans that Plays a Role in the Protection of the Bacteria in the Host
MM Santarem, MT Porto, P Fhrreira, R Soarhs, MP Arala-Chaves
Scandinavian Journal of Immunology 1987
Strong mitogenic effect for murine B lymphocytes of an immunosuppressor substance released by Streptococcus intermedius
MP Arala-Chaves, AS Ribeiro, MM Santarém, A Coutinho
Infection and immunity 1986

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts